AMRO
AMRO
AMsterdam-ROtterdam trial comparing excimer laser & PTCA. A clinical trial comparing two strategies for managing patients with stable angina and coronary lesions of native arteries ≥10 mm on visual assessment, including total or functional occlusions.Primary endpoints Major acute coronary events (MACE)
Conclusion AMRO indicates that excimer laser coronary angioplasty (ELCA) yields no additional benefit in long coronary lesions; ELCA may be optimal for long, >20 mm lesions, aorta-ostial lesions, and total occlusions.